ALEC
Alector, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.46
−1.99%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 31.56x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -27.55x
- Price / sales
- 19.81x
- Price / cash flow
- -1.74x
Enterprise value
- Enterprise value
- $134.6M
- EV / sales
- 9.71x
- EV / EBITDA
- -1.25x
- EV / EBIT
- -1.06x
- Market cap
- $274.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026